Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2013

View Archived Issues

Investigators report discovery of novel allosteric MEK inhibitor CInQ-03

Phase I/II results presented for the long-acting rhGH in children

Moffitt Cancer Center forms strategic partnership with Advinus Therapeutics

Horizon Discovery and Hisun enter agreement

Researchers present a novel mouse model of human myelofibrosis

Belrose Pharma acquires Enzon's advanced drug formulation technology

Vivus study shows avanafil is effective for sexual activity within 15 minutes

QGC-001 is well tolerated at doses of up to 1250 mg

Results announced from first pivotal trial of ALK's allergy immunotherapy tablet

Application seeking approval of tofogliflozin submitted in Japan

MC1R SNPs found to be associated with the severity of RLS

BerGenBio begins phase I trial of BGB-324

Pharmaxis enrolls first subject into pediatric trial evaluating Bronchitol in cystic fibrosis

BioSante Pharmaceuticals and ANI Pharmaceuticals complete merger

PsiOxus Therapeutics begins second study of ColoAd1 vaccine

Intezyne Technologies acquires Niiki Pharma

Novel apoptosis inducers presented by researchers in Barcelona

Novartis prepares novel HDAC4 inhibitors

Paladin's NDA for Impavido granted priority review

ChemoCentryx synthesizes new chemokine receptor antagonists

Boehringer Ingelheim presents novel agents for diabetes and obesity

Volibris tablets granted new Japanese orphan drug designation

OncoSec completes enrollment in phase II ImmunoPulse trial in metastatic melanoma

Merck Serono initiates phase I study of ALX-0761

Evoltra launched in Japan

A new university spin-out raises funding to develop new anticoagulant drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...